杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/25 | 2,162 | 2,166 | 2,131 | 2,158 | -42 | -1.9% | 318,000 |
2020/06/24 | 2,228 | 2,231 | 2,198 | 2,200 | -33 | -1.5% | 180,800 |
2020/06/23 | 2,235 | 2,257 | 2,211 | 2,233 | +5 | +0.2% | 250,700 |
2020/06/22 | 2,219 | 2,238 | 2,202 | 2,228 | +34 | +1.5% | 118,400 |
2020/06/19 | 2,181 | 2,202 | 2,160 | 2,194 | +15 | +0.7% | 199,600 |
2020/06/18 | 2,171 | 2,203 | 2,159 | 2,179 | +41 | +1.9% | 225,600 |
2020/06/17 | 2,144 | 2,165 | 2,130 | 2,138 | ±0 | ±0% | 133,100 |
2020/06/16 | 2,120 | 2,150 | 2,113 | 2,138 | +47 | +2.2% | 236,800 |
2020/06/15 | 2,114 | 2,151 | 2,089 | 2,091 | -45 | -2.1% | 115,300 |
2020/06/12 | 2,112 | 2,146 | 2,093 | 2,136 | -12 | -0.6% | 321,700 |
2020/06/11 | 2,148 | 2,157 | 2,116 | 2,148 | -16 | -0.7% | 275,600 |
2020/06/10 | 2,154 | 2,165 | 2,131 | 2,164 | +24 | +1.1% | 224,800 |
2020/06/09 | 2,168 | 2,168 | 2,092 | 2,140 | -31 | -1.4% | 392,900 |
2020/06/08 | 2,220 | 2,231 | 2,167 | 2,171 | -54 | -2.4% | 249,800 |
2020/06/05 | 2,237 | 2,238 | 2,208 | 2,225 | -24 | -1.1% | 183,800 |
2020/06/04 | 2,286 | 2,295 | 2,240 | 2,249 | -38 | -1.7% | 212,000 |
2020/06/03 | 2,300 | 2,301 | 2,256 | 2,287 | +6 | +0.3% | 230,800 |
2020/06/02 | 2,296 | 2,296 | 2,253 | 2,281 | -7 | -0.3% | 224,600 |
2020/06/01 | 2,330 | 2,334 | 2,286 | 2,288 | -43 | -1.8% | 202,100 |
2020/05/29 | 2,273 | 2,331 | 2,267 | 2,331 | +54 | +2.4% | 435,900 |
2020/05/28 | 2,237 | 2,280 | 2,225 | 2,277 | +44 | +2% | 361,700 |
2020/05/27 | 2,192 | 2,235 | 2,181 | 2,233 | +18 | +0.8% | 329,000 |
2020/05/26 | 2,231 | 2,237 | 2,193 | 2,215 | -9 | -0.4% | 206,100 |
2020/05/25 | 2,194 | 2,230 | 2,184 | 2,224 | +51 | +2.3% | 233,300 |
2020/05/22 | 2,232 | 2,239 | 2,165 | 2,173 | -82 | -3.6% | 238,200 |
2020/05/21 | 2,212 | 2,256 | 2,181 | 2,255 | +58 | +2.6% | 390,500 |
2020/05/20 | 2,160 | 2,207 | 2,160 | 2,197 | +46 | +2.1% | 270,800 |
2020/05/19 | 2,187 | 2,197 | 2,133 | 2,151 | -37 | -1.7% | 261,600 |
2020/05/18 | 2,172 | 2,195 | 2,168 | 2,188 | +30 | +1.4% | 187,000 |
2020/05/15 | 2,177 | 2,205 | 2,138 | 2,158 | -23 | -1.1% | 266,900 |
2020/05/14 | 2,220 | 2,254 | 2,181 | 2,181 | -67 | -3% | 305,200 |
2020/05/13 | 2,243 | 2,283 | 2,225 | 2,248 | -22 | -1% | 589,900 |
2020/05/12 | 2,240 | 2,275 | 2,231 | 2,270 | +30 | +1.3% | 454,900 |
2020/05/11 | 2,206 | 2,243 | 2,206 | 2,240 | +15 | +0.7% | 173,700 |
2020/05/08 | 2,265 | 2,274 | 2,216 | 2,225 | -22 | -1% | 236,600 |
2020/05/07 | 2,226 | 2,264 | 2,224 | 2,247 | +21 | +0.9% | 353,900 |
2020/05/01 | 2,230 | 2,260 | 2,208 | 2,226 | -18 | -0.8% | 237,500 |
2020/04/30 | 2,318 | 2,333 | 2,242 | 2,244 | -78 | -3.4% | 405,500 |
2020/04/28 | 2,328 | 2,328 | 2,280 | 2,322 | -13 | -0.6% | 234,000 |
2020/04/27 | 2,372 | 2,391 | 2,330 | 2,335 | -50 | -2.1% | 290,000 |
2020/04/24 | 2,407 | 2,435 | 2,364 | 2,385 | +18 | +0.8% | 692,400 |
2020/04/23 | 2,310 | 2,379 | 2,310 | 2,367 | +76 | +3.3% | 557,500 |
2020/04/22 | 2,228 | 2,304 | 2,204 | 2,291 | +50 | +2.2% | 477,400 |
2020/04/21 | 2,264 | 2,278 | 2,212 | 2,241 | -43 | -1.9% | 222,100 |
2020/04/20 | 2,305 | 2,328 | 2,280 | 2,284 | -35 | -1.5% | 242,800 |
2020/04/17 | 2,288 | 2,338 | 2,283 | 2,319 | +44 | +1.9% | 574,400 |
2020/04/16 | 2,219 | 2,281 | 2,210 | 2,275 | +76 | +3.5% | 466,000 |
2020/04/15 | 2,229 | 2,229 | 2,173 | 2,199 | -23 | -1% | 215,900 |
2020/04/14 | 2,212 | 2,239 | 2,208 | 2,222 | -14 | -0.6% | 187,100 |
2020/04/13 | 2,212 | 2,236 | 2,184 | 2,236 | +33 | +1.5% | 257,700 |
1201~
1250
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム